PT  - JOURNAL ARTICLE
AU  - Tariq, Amara
AU  - Urooj, Aisha
AU  - Das, Avisha
AU  - Jeong, Jiwoong
AU  - Trivedi, Shubham
AU  - Patel, Bhavik
AU  - Banerjee, Imon
TI  - Domain-specific LLM Development and Evaluation – A Case-study for Prostate Cancer
AID  - 10.1101/2024.03.15.24304362
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.03.15.24304362
4099  - http://medrxiv.org/content/early/2024/03/16/2024.03.15.24304362.short
4100  - http://medrxiv.org/content/early/2024/03/16/2024.03.15.24304362.full
AB  - In this work, we present our strategy for developing domain-specific large language models which cover the vocabulary of the target domain and train on reliable sources of clinical information. Prostate cancer was chosen as a use-case for this study. We collected more than 1.8 million clinical notes and radiology and pathology reports for 15341 patients treated for prostate cancer in Mayo Clinic across three sites and outpatient clinics. In addition to domain-specific training data, we built domain-specific tokenizers and devised knowledge-guided training strategies for LLM development. During the self-supervised training, LLM was forced to predict domain-specific information by marking clinical terms using UMLS parser. We evaluated the model for downstream tasks of clinical information prediction and question answering using quantitative and user evaluation study to measure the accuracy, reliability and information completeness. We compared the domain-specific model against similarly sized general purpose model GPT-2 and a three-times larger domain specialized model. i.e., BioGPT. Our model outperformed GPT-2 on both tasks by a wide margin. Our model was also able to outperform BioGPT on clinical information prediction tasks and showed some advantages over BioGPT in question-answering tasks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Internal Review Board (IRB) of Mayo Clinic gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors